Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial
Open Access
- 8 December 2008
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 373 (9663), 557-566
- https://doi.org/10.1016/s0140-6736(08)61734-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Care at first-level facilities for children with severe pneumonia in Bangladesh: a cohort studyThe Lancet, 2008
- Population Pharmacokinetics of Artesunate and Dihydroartemisinin following Intra-Rectal Dosing of Artesunate in Malaria PatientsPLoS Medicine, 2006
- Epilepsy as a Consequence of Cerebral Malaria in Area in Which Malaria Is Endemic in Mali, West AfricaEpilepsia, 2006
- Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan childrenJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Coping with paediatric referral—Ugandan parents' experienceThe Lancet, 2004
- Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised studyThe Lancet, 2004
- Bioavailability and Preliminary Clinical Efficacy of Intrarectal Artesunate in Ghanaian Children with Moderate MalariaAntimicrobial Agents and Chemotherapy, 2001
- Severe Falciparum Malaria in Children Current Understanding of Pathophysiology and Supportive TreatmentPharmacology & Therapeutics, 1998
- Neurotoxicity in animals due to arteether and artemetherTransactions of the Royal Society of Tropical Medicine and Hygiene, 1994